ASCCP ALGORITHM PDF

Cytology. Since the publication of the consensus guidelines, new cervical cancer screening guidelines have been published and new information has. ASCCP Guideline. HPV Unknown. HPV Positive*. Repeat Cytology. -. @ 12 mos. Cytology. @ 6 & 12 mos OR. HPV DNA Testing. @ 12 mos. ASC or HPV (+) —. Manage per. ASCCP Guideline. HPV Unknown. HPV Positive*. Repeat cytology. >> ASC or HPV (+) > Repeat Colposcopy. @ 12 mos cytology. @6& 12 mos OR.

Author: Kitilar Moogushakar
Country: Somalia
Language: English (Spanish)
Genre: Finance
Published (Last): 20 January 2016
Pages: 223
PDF File Size: 11.84 Mb
ePub File Size: 8.58 Mb
ISBN: 904-6-85810-797-9
Downloads: 89904
Price: Free* [*Free Regsitration Required]
Uploader: Bracage

New data have emerged since publication of the American Society for Colposcopy and Cervical Pathology’s consensus guidelines for management algofithm abnormal cervical cytology and histology.

ASCCP Mobile App – ASCCP

In women with atypical squamous cells—cannot exclude high-grade squamous intraepithelial lesion ASC-Hthe prevalence of CIN 2,3 is as high as 50 percent. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and qlgorithm women in the United States for — Immediate access to this article.

Apgar is a member of the American Society algirithm Colposcopy and Cervical Pathology Board of Directors and author of two colposcopy publications.

  LUTRON LCR 9183 PDF

Screening for cervical cancer Rockville, Md: Good data to support use algoritthm only one option is available. Guidelines were developed by 1 conventional literature review and evidence weighting, and 2 risk-based assessment of various management strategies using observational data from KPNC.

How should I manage women with unsatisfactory Pap results?

Updated Consensus Guidelines FAQs

Good data against use. One of multiple options when data indicate another approach is superior or when no data favor any single option. To see the full article, log in or purchase access.

National Cancer Institute; What should I do? Is conservative treatment for adenocarcinoma in algoritym of the cervix safe? The incidence of HSIL in adolescents is 0. Bethesda implementation and reporting rates: Colposcopic biopsy of lesions suspicious for cancer or CIN 2,3 is preferred in pregnant women, but biopsy of other lesions is acceptable.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: Get immediate access, anytime, anywhere.

Sign up for the free AFP email table of contents. Women with similar risks should be managed similarly. When CIN3 is found in women of any age, treatment is recommended.

Guidelines

Read the full article. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. Endometrial cells in cervical cytology: Baseline cytology, human ascxp testing, and risk for cervical neoplasia: Obtaining a specimen for histologic evaluation by endometrial biopsy, dilatation and curettage, or hysteroscopy.

  BALL EASTAWAY HOUSE PDF

Continue reading from July 15, Previous: This content is owned by the AAFP. How should I manage women with discordant cotesting results? Counseling on Early Childhood Concerns: In general, cytology should ascvp repeated in months.

Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Accp squamous cells of undetermined significance: The relationship of cervical intraepithelial neoplasia, grades 2 and 3 CIN 2,3 and cervical cancer to HPV infection is well established. Colposcopy is preferred for pregnant women with low-grade squamous intraepithelial lesion and high-grade squamous intraepithelial lesion, but evaluation of the former may be deferred until no earlier than six weeks postpartum.

Clinical applications of HPV testing: Obtaining a cytologic sample with a cytobrush or histologic specimen by a cytobrush or endocervical curette.